No abstract available
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alleles
-
Antineoplastic Agents, Hormonal / pharmacokinetics
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Biotransformation / drug effects
-
Breast Neoplasms / complications
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Citalopram / adverse effects
-
Citalopram / pharmacology
-
Citalopram / therapeutic use
-
Cytochrome P-450 CYP2D6 / genetics
-
Cytochrome P-450 CYP2D6 / metabolism
-
Cytochrome P-450 CYP2D6 Inhibitors*
-
Denmark / epidemiology
-
Depression / complications
-
Depression / drug therapy
-
Drug Interactions
-
Estrogens*
-
Female
-
Humans
-
Neoplasms, Hormone-Dependent / drug therapy*
-
Neoplasms, Hormone-Dependent / mortality
-
Prognosis
-
Recurrence
-
Selective Serotonin Reuptake Inhibitors / adverse effects
-
Selective Serotonin Reuptake Inhibitors / pharmacology*
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Tamoxifen / analogs & derivatives
-
Tamoxifen / blood
-
Tamoxifen / pharmacokinetics
-
Tamoxifen / therapeutic use*
Substances
-
Antineoplastic Agents, Hormonal
-
Cytochrome P-450 CYP2D6 Inhibitors
-
Estrogens
-
Serotonin Uptake Inhibitors
-
Tamoxifen
-
Citalopram
-
4-hydroxy-N-desmethyltamoxifen
-
Cytochrome P-450 CYP2D6